ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselLuzsana Biotechnology Europe AG
Luzsana Biotechnology Europe AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Luzsana Biotechnology Europe AG is the development and marketing of innovative medicines, particularly in the field of biotechnology. The company focuses on conducting clinical trials and global distribution of medicines to make them accessible to patients worldwide.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.0/5

Luzsana Biotechnology Europe AG

✓ Offered2
Drug Development
R&D pipeline with clinical development programs for Camrelizumab, Fuzuloparib and a Claudin 18.2 ADC in phases I to III and submission.
Clinical Trials
Clinical trials program with studies on Camrelizumab, Fuzuloparib and a Claudin 18.2 ADC, including phase I/II and phase III studies with patient populations.
Trust & reputation

ranQ Trust Score of Luzsana Biotechnology Europe AG: 4.0 out of 5.0

Trust Score4.0/ 5.0

High

x

Data basis 54% · As of October 2026

Luzsana Biotechnology Europe AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Luzsana Biotechnology Europe AG scores 72.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Luzsana Biotechnology Europe AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Luzsana Biotechnology Europe AG scores 14.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.14.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Luzsana Biotechnology Europe AG reaches a ranQ Trust Score of 4.0 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Luzsana Biotechnology Europe AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Luzsana Biotechnology Europe AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Luzsana Biotechnology Europe AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Luzsana Biotechnology Europe AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Barfüsserplatz 3
4051 Basel

At a glance

Legal form
Corporation
UID
CHE-478.663.045
Founded
2020 · 6 years
Last commercial register change
January 24, 2024
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.100.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    BM
    BeOne Medicines I GmbH
    Basel
    US
    Urovant Sciences GmbH
    Basel
    RM
    Revolution Medicines Switzerland GmbH
    Basel
    LP
    Luye Pharma Switzerland AG
    Basel
    IP
    Ironwood Pharmaceuticals GmbH
    Basel
    NP
    Novartis Pharma AG
    Basel
    BI
    Boehringer Ingelheim (Schweiz) GmbH
    Basel
    RS
    Regeneron Switzerland GmbH
    Basel